If you look closely at what has become the new foc

If you look closely at what has become the new focus it is everything HIV. Combo bla, mono pivotal, PReP, cure and now Nash/fibrosis. In my opinion they are making the HIV side sexy as hell for any potential suitor knowing that the other indications are a little further away from approval. If Nash is effective leronlimab would be prescibed in any combo therapy and if Mono works the whole Market is cornered.